James L. Tyree, Director at ChemoCentryx, Inc. (CCXI), sold 60,000 shares at $37.44 ($2.2M) on 2020-01-13, disclosed to the SEC on 2020-01-15.
Open-market sale of $2.2M CCXI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.69 | 15,285 | $561K | 25.2% |
| 2 | $36.69 | 15,285 | $561K | 25.2% |
| 3 | $37.44 | 14,715 | $551K | 24.8% |
| 4 | $37.44 | 14,715 | $551K | 24.8% |
| Total | $37.06 avg | 60,000 | $2.2M | 100% |
| Filing → |
| ASRT | SELL | 2024-03-15 | $11K | — | Filing → |
| GNLX | SELL | 2023-12-14 | $192K | — | Filing → |
| ASRT | SELL | 2023-05-05 | $259K | — | Filing → |